Merck-marketed asthma drug linked to psychiatric issues: report

magicmine/iStock via Getty Images A widely used asthma therapy first marketed by Merck ( NYSE: MRK ) may be associated with severe mental issues, including suicidal thoughts, for some patients, Reuters reported Friday, citing a scientific presentation. According to researchers, the drug branded as Singulair and is now.